SG76535A1 - Pharmaceutical agents - Google Patents

Pharmaceutical agents

Info

Publication number
SG76535A1
SG76535A1 SG1998000280A SG1998000280A SG76535A1 SG 76535 A1 SG76535 A1 SG 76535A1 SG 1998000280 A SG1998000280 A SG 1998000280A SG 1998000280 A SG1998000280 A SG 1998000280A SG 76535 A1 SG76535 A1 SG 76535A1
Authority
SG
Singapore
Prior art keywords
pharmaceutical agents
pharmaceutical
agents
Prior art date
Application number
SG1998000280A
Other languages
English (en)
Inventor
Mitchell Irvin Steinberg
Fatima Emitsel Yakubu-Madus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SG76535A1 publication Critical patent/SG76535A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG1998000280A 1997-02-11 1998-02-10 Pharmaceutical agents SG76535A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79866197A 1997-02-11 1997-02-11

Publications (1)

Publication Number Publication Date
SG76535A1 true SG76535A1 (en) 2000-11-21

Family

ID=25173964

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1998000280A SG76535A1 (en) 1997-02-11 1998-02-10 Pharmaceutical agents

Country Status (12)

Country Link
EP (1) EP0857483A1 (fr)
JP (1) JPH10218773A (fr)
KR (1) KR19980071226A (fr)
AU (1) AU5387898A (fr)
CA (1) CA2229123A1 (fr)
CZ (1) CZ39398A3 (fr)
HU (1) HUP9800291A2 (fr)
IL (1) IL123232A0 (fr)
MX (1) MX9801129A (fr)
NO (1) NO980546L (fr)
SG (1) SG76535A1 (fr)
ZA (1) ZA981029B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
ITTV20010002U1 (it) 2001-01-12 2002-07-12 Vetraria Biancadese Sas Soc Tavolo avente almeno una prolunga estraibile mediante semplice rotazione
GEP20084540B (en) 2003-01-14 2008-11-25 Arena Pharm Inc 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
CN1751038A (zh) * 2003-02-24 2006-03-22 艾尼纳制药公司 作为葡萄糖代谢调节剂的经取代芳基和杂芳基衍生物及葡萄糖代谢失调的预防和治疗
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
KR101137084B1 (ko) * 2003-10-10 2012-04-24 애보트 프러덕츠 게엠베하 셀렉티브 ⅰ1 이미다졸린 수용체 작용제 및 엔지오텐신 ⅱ수용체 차단제를 포함하는 약학적 조성물
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
AU2007213887A1 (en) * 2006-01-27 2007-08-16 F. Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of CNS disorders
KR101176699B1 (ko) 2006-10-19 2012-08-23 에프. 호프만-라 로슈 아게 아미노메틸-4-이미다졸
ATE533755T1 (de) 2006-11-02 2011-12-15 Hoffmann La Roche Substituierte 2-imidazole als modulatoren der mit spurenaminen assoziierten rezeptoren
RU2456281C2 (ru) 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
BRPI0720047A2 (pt) 2006-12-13 2013-12-24 Hoffmann La Roche 2-imidazóis como ligantes para receptores associados a aminas de traço (taar)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
CA2675221C (fr) 2007-02-02 2016-02-23 F. Hoffmann-La Roche Ag Nouvelles 2-aminooxazolines servant de ligands du taar1 pour des troubles du snc
KR101222412B1 (ko) 2007-02-15 2013-01-15 에프. 호프만-라 로슈 아게 Taar1 리간드로서의 2-아미노옥사졸린
WO2009003868A2 (fr) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2-imidazolines
CA2691704A1 (fr) 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines et leur utilisation comme antidepresseurs
BRPI0813837A2 (pt) 2007-07-27 2015-01-06 Hoffmann La Roche 2-azetidinametanoaminas e 2-pirrolidinametanoaminas como ligantes de taar
JP5341084B2 (ja) 2007-08-03 2013-11-13 エフ.ホフマン−ラ ロシュ アーゲー Taar1リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
CA2812061A1 (fr) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulateurs du recepteur gpr119 et traitement des troubles qui lui sont lies
EP2829540A1 (fr) 2013-07-26 2015-01-28 Abbott Healthcare Products B.V. Synthèse d'aminopyridines substituées
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
KR102603199B1 (ko) 2015-06-22 2023-11-16 아레나 파마슈티칼스, 인크. S1p1 수용체-관련 장애에서의 사용을 위한 (r)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[b]인돌-3-일)아세트산 (화합물 1)의 결정성 l-아르기닌 염
AU2017234042B2 (en) 2016-03-17 2020-11-19 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of TAAR

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel

Also Published As

Publication number Publication date
CZ39398A3 (cs) 1998-08-12
IL123232A0 (en) 1999-11-30
JPH10218773A (ja) 1998-08-18
KR19980071226A (ko) 1998-10-26
ZA981029B (en) 1999-08-10
HUP9800291A2 (hu) 2001-02-28
CA2229123A1 (fr) 1998-08-11
NO980546D0 (no) 1998-02-09
AU5387898A (en) 1998-08-13
HU9800291D0 (en) 1998-04-28
EP0857483A1 (fr) 1998-08-12
NO980546L (no) 1998-08-12
MX9801129A (es) 1998-11-29

Similar Documents

Publication Publication Date Title
PL340337A1 (en) Drugs
SG76535A1 (en) Pharmaceutical agents
GB9700504D0 (en) Pharmaceutical compounds
GB9706089D0 (en) Pharmaceutical composition
GB9726563D0 (en) Novel pharmaceutical
GB9726566D0 (en) Novel pharmaceutical
EP1003495A4 (fr) Composes pharmaceutiques
EG23694A (en) Novel pharmaceutical
GB9716244D0 (en) Pharmaceutical compounds
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
GB9717428D0 (en) Pharmaceutical composition
GB9700555D0 (en) Therapeutic agents
GB9700895D0 (en) Pharmaceutical compounds
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
GB9706376D0 (en) Novel pharmaceutical
GB9726781D0 (en) Pharmaceutical composition
IL136525A0 (en) Agents
EP1095026A4 (fr) Agents pharmaceutiques
GB2329335B (en) Medicament
ZA987535B (en) Pharmaceutical compounds
GB9717832D0 (en) Pharmaceutical compounds
GB9717041D0 (en) Pharmaceutical compounds
GB9706302D0 (en) Pharmaceutical compounds